Yes — semaglutide and tirzepatide can trigger hair loss, but it’s rarely the drug acting on your follicles directly. The shedding some patients notice a few months into GLP-1 treatment is typically telogen effluvium, a temporary, diffuse hair loss triggered by rapid weight loss, calorie restriction, and shifting nutrient intake — not permanent, pattern-baldness-style thinning. For most patients, hair density recovers within six to nine months once weight stabilizes and nutrition catches up.
Why Do GLP-1 Medications Cause Hair Shedding?
Every hair follicle cycles through three phases: growth (anagen), transition (catagen), and rest (telogen), before the hair sheds and a new one grows in its place. Normally, only 5–10% of scalp hairs sit in the resting phase at any given time. A significant physiologic stressor — rapid weight loss, a sharp calorie deficit, surgery, illness, or crash dieting — can push a much larger share of follicles into that resting phase at once. Roughly two to four months later, all of those hairs shed together, producing the diffuse thinning patients associate with telogen effluvium.
Semaglutide and tirzepatide suppress appetite and often drive substantial, sometimes fast, weight loss. That process creates exactly the kind of metabolic stress that can trip this shedding cycle. It’s a well-documented consequence of significant weight loss in general — seen after bariatric surgery and very-low-calorie diets long before GLP-1 medications existed — rather than a direct pharmacologic effect of GLP-1 receptor agonists on hair follicles.
It’s the weight loss, not the molecule
Case reports and patient registries suggest hair shedding affects a minority of people on GLP-1 therapy, and it’s more common in those losing weight quickly — generally faster than about 1–2% of body weight per month — or those taking in inadequate protein and micronutrients during the adjustment period. Slower, more gradual weight loss with adequate nutrition appears to lower the risk.
GLP-1 Shedding vs. Androgenic Hair Loss: How to Tell Them Apart
Telogen effluvium and androgenic (pattern) hair loss look and behave differently, and confusing the two can lead to the wrong treatment. Telogen effluvium from a GLP-1 medication causes diffuse thinning across the entire scalp — you’ll notice more hair in the shower drain and on your pillow, but no distinct bald patches. Androgenic hair loss, by contrast, follows a predictable pattern: a receding hairline, thinning at the crown, or both, driven by DHT’s effect on genetically susceptible follicles. That’s the process treatments like finasteride and minoxidil are designed to interrupt — see our guide to how finasteride and minoxidil work for the mechanism.
The two can overlap. If you were already genetically predisposed to male pattern baldness, a bout of GLP-1-related telogen effluvium can make existing thinning more noticeable, even after the shedding itself resolves. If your hair loss follows a hairline or crown pattern rather than an all-over pattern, or it doesn’t improve once your weight has stabilized for a few months, it’s worth having it evaluated as a separate, DHT-driven issue rather than assuming it will resolve on its own.
Timeline: When Does It Start, and When Does It Stop?
Onset: two to five months in
Because of the delay built into the hair cycle, shedding usually doesn’t show up right when you start a GLP-1 medication. Most patients notice it two to five months after starting treatment, or two to four months after a period of especially rapid weight loss — for example, right after a dose increase that accelerated things.
Peak and recovery: six to twelve months
Shedding typically peaks within a few weeks of onset, then gradually tapers as weight loss slows and the body adjusts. Full regrowth follows the hair cycle’s own timeline — most patients see visibly thicker hair again within six to twelve months, even without stopping treatment.
How to Protect Your Hair While Losing Weight on Semaglutide or Tirzepatide
A few adjustments during treatment can reduce the odds of noticeable shedding, or shorten it when it happens:
- Prioritize protein. Aim for roughly 0.6–0.8 grams per pound of body weight daily — hair is largely built from protein, and intake often drops along with appetite.
- Don’t outpace the recommended titration. Slower, steadier weight loss is associated with less shedding than very rapid drops.
- Check key labs. Ferritin, vitamin D, zinc, and B12 deficiencies are common when food intake falls, and each can independently worsen shedding.
- Consider a daily multivitamin to cover gaps while your appetite and intake are still adjusting.
- Give it time. Most GLP-1-related shedding is self-limited and resolves without any change in treatment.
For a broader look at what else to expect while titrating up, see our guide to tirzepatide side effects, and if pattern-style thinning is layered on top of general shedding, our overview of hair loss treatments that actually work covers the options.
Frequently Asked Questions
Does hair loss from semaglutide or tirzepatide grow back?
In most cases, yes. Because the shedding is typically telogen effluvium rather than androgenic hair loss, it isn’t permanent. Once weight loss slows and nutrition stabilizes, follicles re-enter the growth phase and hair density typically returns within six to twelve months.
Should I stop taking my GLP-1 medication if I notice hair shedding?
Don’t stop or adjust your dose on your own — talk to your prescriber first. For most patients, shedding is temporary and resolves without changing treatment. Your provider can check your labs, review your rate of weight loss, and make sure something else isn’t contributing before deciding whether any adjustment is needed.
Is tirzepatide more likely to cause hair loss than semaglutide?
There’s no strong evidence that one medication carries meaningfully higher risk than the other. Because hair shedding tracks with the rate and amount of weight loss rather than the specific drug, the medication that produces faster weight loss for a given patient may carry a somewhat higher chance of noticeable shedding — regardless of which GLP-1 it is.
Hair shedding on a GLP-1 medication can be unsettling, but for most patients it’s a temporary side effect of rapid weight change rather than a sign something is wrong. If you’re considering semaglutide or tirzepatide, or you’re already on one and want your treatment plan reviewed with this in mind, explore RespondWell’s weight loss programs to get started with a provider who can help you lose weight at a pace that protects your results — hair included.